FindTrial
Sign In

Effect of transcutaneous acupoint electrical stimulation combined with dexmedtomidine in treating postoperative nausea andvomiting in patients undergoing craniotomy

Effect of transcutaneous acupoint electrical stimulation combined with dexmedtomidine in treating postoperative nausea andvomiting in patients undergoing craniotomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007303
Enrollment
Unknown
Registered
2015-09-20
Start date
2015-10-21
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea andvomiting

Interventions

Group 2:Dexmedetomidine
Group 3:Transcutaneous electrical stimulation+Azasetron
Group 4:Dexmedetomidine+TENS+Azasetron
Group 1:Azasetron

Sponsors

An Hui Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. ASA class I-II; 2. Aged between 18 and70 years old; 3. Scheduled for neurosurgery requiring opening of the dura; 4. Undergoing general anesthesia; 5. No use of antiemetic 24 hours before surgery; 6. No history of PONV or motion sickness.

Exclusion criteria

Exclusion criteria: 1. Nausea or vomiting 24 hours before surgery; 2. Pregnant or lactating women; 3. Drug or alcohol abusers; 4. Cardiac pacemaker; 5. Refusal to accept TENS treatment; 6. Cannot normally communicate; 7. History of epilepsy andstill taking an antiepileptic medicine.

Design outcomes

Primary

MeasureTime frame
Postoperative nausea andvomiting;—

Secondary

MeasureTime frame
Serum gastrin;—

Countries

China

Contacts

Public ContactLi Juan
51224064@qq.com+86 13956005465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026